IGC Pharma (IGS1.MU) Q2 2026 Earnings

20MayConfirmed
Q2 2026
-0.02
0.32
0.65
0.98

Details

Expected EPS
-0.0172062
Actual EPS
-0.0172062
Surprise EPS
0
Surprise Percent
+0%

Description

IGC Pharma (IGS1.MU) has reported earnings of -0.0172062 per share for Q2 2026.

0 Comments

Share your thoughts